Akebia Therapeutics Inc. buy Piper Sandler
Start price
31.05.23
/
50%
€0.92
Target price
31.05.24
-
Performance (%)
13.76%
End price
01.06.24
€1.05
Summary
This prediction ended on 01.06.24 with a price of €1.05. The prediction had a final performance of 13.76%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 8.540% | 8.540% | 4.455% |
| iShares Core DAX® | 1.280% | 1.320% | 13.605% |
| iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% |
| iShares Nikkei 225® | -2.006% | -1.389% | 8.973% |
| iShares S&P 500 | -0.662% | -1.884% | 23.684% |
Comments by Piper_Sandler for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten